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Objectives: Prevalence, clinical characteristics and severity of gradual onset injuries (GOIs) in cyclists are
poorly documented. We determine the prevalence, anatomical regions/sites affected and severity of GOIs
among entrants in a community-based mass participation event.
Design: Cross-sectional study;
Setting: Cape Town Cycle Tour;
Participants: Race entrants.
Main outcome measures: Of 35,914 entrants, 27,349 completed pre-race medical questionnaires. We
studied 21,824 consenting cyclists (60.8% of entrants). Crude lifetime prevalence, retrospective annual
incidence, anatomical region/sites, specific GOI, tissue type and GOI severity is reported.
Results: The lifetime prevalence of GOIs was 2.8%, with an annual incidence of 2.5%. More common
anatomical regions affected by GOIs were lower limb (43.4%), upper limb (19.8%), and lower back (11.5%).
The knee (26.3%), shoulder (13%), and lower back (11.5%) regions were mostly affected. The most com-
mon GOI was anterior knee pain (14.2%). Of the GOIs, 55% were in soft tissue. 50% of cyclists reported
symptom duration >12 months, and 37.3% of GOIs were severe enough to reduce/prevent cycling.
Conclusion: 2.5% recreational cyclists report a GOI annually. >50% of GOIs affect the knee, lower back and
shoulder. GOIs negatively affect cycling. Risk factors related to GOIs in cyclists need to be determined to
develop and implement prevention programs.
© 2020 Elsevier Ltd. All rights reserved.1. Introduction
The burden of non-communicable diseases (NCDs) of lifestyle
can be reduced by a healthy lifestyle that includes participation in
regular moderate-to high-intensity physical activity for >150 min/
week (Bahr et al., 2020; Khan et al., 2012; Kohl et al., 2012). Mass
community-based participation in sport and endurance events,nd Lifestyle Institute (SEMLI),
orts Campus, Burnett Street,
chwellnus).such as cycling, is therefore encouraged as part of a healthy lifestyle
and a substantial growth in race entrants has been observed in
South African events such as the annual 109 km Cape Town Cycle
Tour (CTCT) and multi-stage mountain-bike races (Cape Epic,
Wines to Whales).
Cycling injuries can be acute/traumatic injuries caused by falls
or injuries can be of a more gradual onset. As cycling gains popu-
larity there may be an increased number of injuries amongst both
amateur and professional cyclists (Clarsen et al., 2010; Dettori &
Norvell, 2006; Kotler et al., 2016). The prevalence of gradual
onset cycling injuries is as high as 85% (Dettori & Norvell, 2006).
Other SAFER studies have focused on the traumatic injuries in
F. du Toit, M. Schwellnus, P. Wood et al. Physical Therapy in Sport 46 (2020) 113e119cyclists (Killops et al., 2020). Gradual onset injuries (GOIs) in cy-
clists are associated with long, repetitive training sessions (Clarsen
et al., 2013; Decalzi et al., 2013), thus this paper will focus on the
GOIs in cyclists.
The epidemiology of GOIs in cyclists is not well described. In one
review, dating back to 2006, it was reported that GOIs in cyclists
mainly affect the knee, ankle, back, neck/shoulders, hands/wrists,
and the buttocks/perineum (Dettori & Norvell, 2006). More
recently, the epidemiology of GOIs among professional cyclists that
attend training camps was studied (Clarsen et al., 2010). In this
study, lower back pain, anterior knee pain and neck-shoulder pain
were found to be the most frequently reported GOIs. Recreational
or amateur cyclists make up the largest number of cyclists, yet there
are few studies reporting the epidemiology GOIs in this population.
In one study, buttock pain, knee injuries, specifically ‘patellar pain
syndrome’ and neck-shoulder pain were common among amateur
cyclists during a 5 days cycle tour (Clarsen et al., 2010; Weiss,
1985), In a more recent study, 88% of amateur cyclist partici-
pating in a 1-day 94.7 km cycle challenge reported a GOI, with the
neck, back, hand/worst and buttock/perineum being the common
anatomical areas affected (Van der Walt et al., 2014). However, it is
difficult to compare data on the clinical characteristics, including
severity, of GOIs in cyclists between studies because of methodo-
logical differences in recording of GOIs (Clarsen et al., 2015) and
differences in cycling populations studied e.g. professional and
recreational cyclist differ significantly in annual cycling exposure,
training history and equipment selection. Other epidemiological
studies on GOIs in road cyclists mainly refer to leisure or trans-
portation activities. Currently, little is known about GOIs in mass-
participation cycling events that attract recreational cyclists,
despite the fact that GOIs are very common (Weiss, 1985; Wilber
et al., 1995).
Therefore, the aim of this study was to describe the epidemi-
ology (lifetime prevalence, retrospective annual incidence), clinical
characteristics (main anatomical region and specific anatomical
sites affected, prevalence of specific common GOIs, and to describe
these by tissue type affected), and severity (duration of symptoms
and severity grade) in recreational cyclists that entered for a large
community-based cycling event.
2. Methods
This descriptive cross-sectional study formed part of a series of
on-going SAFER (Strategies to reduce Adverse medical events For
the ExerciseR) studies (Schwellnus & Derman, 2014). The Research
Ethics Committee of the Faculty of Health Sciences approved the
study (REC numbers 431/2015 and 213/2017). Data collection for
the SAFER studies is ongoing, and this study was an analysis of data
collected over a one-year period (2016).
A total of 35,914 cyclists entered the 109 km Cape Town Cycle
Tour (CTCT) in 2016, and 21,902 cyclists gave informed consent for
their data to be used for research purposes. In 78 cyclists there was
missing or incomplete data, therefore, the final study population
was 21,824 (60.8% of all cycle race entrants).
All cycle race entrants from the 2016 CTCT were required to
complete an online medical questionnaire at the time of registra-
tion. The online medical screening tool consisted of a series of
questions that were developed to specifically provide clinical in-
formation for medical staff in order to improvemedical care on race
day. The main sections of the medical screening tool were based on
the guidelines for cardiovascular evaluation of middle-aged/senior
individuals engaging in leisure-time sport activities (Position stand
from the European Association of Cardiovascular Prevention and
Rehabilitation) (Borjesson et al., 2011), and adapted from our pre-
vious studies in distance runners (Rotunno et al., 2018; Schwabe114et al., 2018). The detailed methodology of the online medical
screening tool development and implementation was described in
previous studies amongst endurance runners (Rotunno et al., 2018;
Schwabe et al., 2018). Additional questions, specifically related to
common medical complications encountered during cycling, were
added. The final screening questions related to the cyclists’ training
and medical history including history of acute traumatic and GOIs
(current, or in the last 12 months).
In keeping with a recent IOC consensus paper (Bahr et al., 2020),
we recognise that cycling injuries result from a transfer of kinetic
energy (agent) that damages tissue. This transfer of energy may
result from: 1) a near-instantaneous exchange of large quantities of
kinetic energy (e.g. cycling accident), 2) from the gradual accu-
mulation of low-energy transfer over time (as in the development
of patellofemoral pain), or 3) from a combination of both mecha-
nisms (repetitive training regime resulting in discal lower back pain
that then manifests itself acutely following a minor cycling acci-
dent) (Bahr et al., 2020). We agree that mode of onset for injuries
should be conceptualized as a continuum interplay of energy ex-
posures. However, in our medical screening tool, which was
designed prior to the recent IOC consensus statement (Bahr et al.,
2020), cyclists were specifically asked the following question
related to injuries: “Do you or did you suffer from any symptoms of a
CHRONIC (no accident) cycling injury (muscles tendons bones liga-
ments or joints) IN YOUR CYCLING CAREER?“. We therefore included
only injuries where there was no self -reported history of a near-
instantaneous exchange of large quantities of kinetic energy (e.g.
cycling accident), and we report these as GOIs. The severity of a GOI
was defined as: “An injury that is/was severe enough to interfere with
cycling or require treatment e.g. use medication or require you to seek
medical advice from a health professional”.
In response to a “yes” answer to this question, participants were
required to complete additional questions with drop-down boxes
that were related to the GOIs, including: past or current injury, side
of the body the injury occurred (if applicable), anatomical site, type
of anatomical structure, severity, duration of symptoms, and
whether the injury was one of the more commonly known GOIs. A
GOI was reported by 617 cyclists and 29 cyclists reportedmore than
one GOI (total of 646 GOIs).
In this study, we report the following epidemiological outcome
variables in the 617 cyclists reporting a GOI: lifetime prevalence of
GOIs (% cyclists reporting a GOI in their lifetime career of cycling),
and retrospective annual incidence of GOICs (% cyclists reporting a
GOI in the past 12 months). The lifetime prevalence of GOIs was
determined in response to a yes answer for “an injury in the cyclists
cycling career”. The retrospective annual incidence of GOIs was
determined in response to a yes answer for “an injury in the past 12
months or currently”.
The clinical characteristic outcome variables for 646 GOIs were
as follows: main anatomical region and specific anatomical site of
GOIs, specific common GOIs and GOIs by tissue type affected
(muscle, tendon, ligament, bone, joint, nerve).
We report on the severity of GOIs (n ¼ 646) as follows: duration
of symptoms (0e3 months, 4e12 months and >12 months), and an
injury severity grading (Grade I-IV) commonly used for “overuse”
injuries in sport (Taunton et al., 2003). For the purposes of
comparing the grading of injuries to that of other studies, we also
report GOIs severity in two categories of severity: a) less severe,
where cyclists are still able to cycle and compete with no or min-
imal interference (Grade I and Grade II), and b) more severe, where
the GOIs interferes with the cyclists’ ability to, and even stop them
from, training or competing (Grade III and Grade IV).
All questionnaire data were entered into an Excel spreadsheet
(Microsoft 2010) and analysed using the SAS v9.4 statistical pro-
gram. Only data for consented cycle race entries were used for
Table 2
Gradual onset injuries (GOIs) in cyclists by anatomical region and specific anatom-
ical sites of GOIs (expressed as % of all GOIs) (n ¼ 646).
Main anatomical region Specific anatomical sites n % of all GOIs









Upper arm 1 0.2
Forearm 1 0.2
Trunk/Chest All 16 2.5
Back chest 9 1.4
Front chest 7 1.1
Lower Back All 74 11.5
Hip/Groin/Pelvis All 69 10.7
Hip 32 5.0
Hip muscle # 26 4.0
Groin 11 1.7
Lower Limbs All 281 43.4
Knee 170 26.3
Achilles 22 3.4
Hamstring muscle 18 2.8
Foot 18 2.8
Calf muscle 17 2.6
Ankle 17 2.6
Quadriceps muscle 11 1.7
Shin/Lower leg 8 1.2
Other All 41 6.4
n: number of injuries reported in the study.
% Gradual onset injuries frequency (%) of reported injuries in the study.
# including gluteal (buttock) muscles.
F. du Toit, M. Schwellnus, P. Wood et al. Physical Therapy in Sport 46 (2020) 113e119analysis (n ¼ 21824). The lifetime prevalence of GOIs (muscles,
tendons, bones, ligaments or joints), the retrospective annual
incidence of GOIs and the point prevalence are reported, consid-
ering the correlation resulting from the same cyclist reporting
multiple injuries.
GOIs in the main anatomical region, specific anatomical sites,
specific common GOIs, tissue and type of GOIs are described with
frequencies and percentages out of all GOIs. The duration of
symptoms (months) of GOIs are categorized as of 0e3 months,
4e12 months, and >12 months, and the frequency (%) is reported
for each category overall, as well as by main anatomical region.
3. Results
Although the response rate was acceptable, a post-hoc analysis
was conducted to determine if the participants in this study were
indeed representative of all the cycle race entrants. The de-
mographics (age and gender) of all cyclists entering the 2016 CTCT
are compared with the consenting cycle race entrants that were
participants in this study (Table 1).
We note that, in our study population, there were significantly
more cyclists over 50 years old (p < 0.0001), as well as a higher % of
male cyclists (p ¼ 0.0390), compared with all cycle race entrants
(Table 1).
The point prevalence (at the time of race registration) of GOI in
this population (n ¼ 21824) was 1.1% (95%CI: 0.9e1.2; n ¼ 230), the
lifetime prevalence of GOIs was 2.8% (95%CI: 2.6e3.1; n ¼ 617), and
the retrospective annual incidence of GOIs was 2.5% (95%CI:
2.3e2.7; n ¼ 551).
The frequency (%) of GOIs by main anatomical region and spe-
cific anatomical sites is depicted in Table 2.
The main anatomical region of GOIs (as a % of all GOIs) was the
lower limb region (43.4%), followed by the upper limb (19.8%),
lower back (11.5%), and hip/groin/pelvis (10.7%). Within the main
anatomical regions, the three most affected specific anatomical
sites for GOIs were the knee (26.3%), shoulder (13%), and the lower
back (11.5%).
A list of common reported GOIs were included in the ques-
tionnaire and for 76.3% (n ¼ 609) of injuries, cyclists reported a
specific common GOI. The frequency (%) of specific common GOIs is
listed in Table 3.
The four most specific common GOIs asked were anterior knee
pain (AKP)/Patellofemoral pain (PFP) (14.2%), lower back pain (LBP)
(10.5%), shoulder injury (9.4%) and the iliotibial band friction syn-
drome (ITBFS) (8.5%) respectively.
The frequency (%) of GOIs by tissue type is depicted in
Supplementary Table S1. In 98.8% of injuries (n ¼ 637) the cyclist
reported a tissue type. The majority of GOIs were to the soft tissues
(muscle, tendon, ligament and nerve) (55%), and 35.6% of GOIs were
reported as musculotendinous. The specific tissue type in which
cyclists reported GOIs (% of all injuries) weremuscle (19%), followed
by bone (18.9%), and tendon (16.6%).Table 1
Characteristics of all cycle race entrants and study participants (consenting cycle race en




Age groups (years) 30 6453
31 to 40 7814
41 to 50 10583
>50 11064
p: p-value - all cycle race entrants vs. entrants consenting as study participants.
115A further analysis of the frequency (%) of GOIs by type of tissue
in the main anatomical region is depicted in Supplementary
Table S2. The most common tissue affected by GOIs in the lower
limb was tendon (26.3%), whilst bone was the most common tissue
affected by GOIs in the upper limb (32%) and trunk/chest (75%).
Cyclists also reported the duration of symptoms of the GOI, and
this was reported in 76.3% (n ¼ 609) of injuries. The duration of
symptoms was categorized as follows: 0e3 months, 4e12 months,
and >12 months (Supplementary Figure S1). In 47.8% of GOIs,
symptoms lasted >12 months. This was followed by a symptom
duration of 4e12 months in 33.8% of GOIs, and only in 18.4% of the
GOIs were symptoms present for <3 months.
The frequency (%) of reported GOIs in each main anatomical
region by duration of symptoms category is depicted in
Supplementary Table S3. Of the reported GOIs by main anatomical
region, 63.8% hip/groin/pelvis, 59.5% head/neck/face, and 59.5%
lower back injuries were reported as having a symptom duration of
>12 months. The symptom duration was shorter for some
anatomical regions than for others (p ¼ 0.003). On average, the
duration of symptoms of GOIs was shorter in the trunk/chest regiontrants).
s study participants (n ¼ 21824) p
n %
78.8 17282 79.2 p ¼ 0.0390
21.2 4542 20.8





Specific common gradual onset injuries (GOIs) (expressed as % of all GOIs) (n ¼ 646).
Specific common gradual onset injuries (GOIs) in cyclists n % (of all GOIs)
Knee - Anterior knee pain (AKP)/Patellofemoral pain (PFP) 92 14.2
Lower back pain (LBP) 68 10.5
Shoulder pain 61 9.4
Knee - Iliotibial band friction syndrome (ITBFS) 55 8.5
Hip joint pain 30 4.7
Neck pain 28 4.3
Hip muscle injury (including gluteus/buttock muscles) 23 3.6
Achilles tendon injury 22 3.4
Numbness in the hand/fingers 21 3.3
Foot or heel pain 19 2.9
Calf muscle injury 16 2.5
Hamstring injury 16 2.5
Elbow pain 15 2.3
Wrist pain 10 1.6
Quadriceps muscle injury 5 0.8
Groin/genital numbness 6 0.9
Saddle sores 6 0.9
Other 116 18.0
Injuries where specific commonly reported GOIs data were missing 37 5.7
n: number of injuries reported in the study.
% Gradual onset injuries frequency (%) of reported injuries in the study.
F. du Toit, M. Schwellnus, P. Wood et al. Physical Therapy in Sport 46 (2020) 113e119(p ¼ 0.0002) and longer for hip/groin/pelvis (p ¼ 0.006) and lower
back (p¼ 0.039) regions compared to the other anatomical regions.
The frequency (%) of GOIs severity (grade IeIV) is depicted in
Supplementary Table S4. Of the reported injuries, 93.2% (n ¼ 602)
reported severity grading and out of those, >37% were severe
enough to interfere with the cyclist’s ability to, and even stop them
from, training or competing.
The frequency (%) of GOIs severity (grade IeIV) by main
anatomical region is depicted in Supplementary Table S5 (% of re-
ported GOIs by main anatomical region). The severity grading was
similar for all anatomical regions, with no one region reporting a
more severe grading compared to the other regions (p ¼ 0.616).
4. Discussion
The main findings of this study were 1) 2.8% of recreational
cyclists reported a GOI in their cycling career (about 1 in 35 cy-
clists), with an annual incidence of 2.5%, and a 1.1% point prevalence
at the time of race registration 2) the lower limb was the most
commonly affected by GOIs (43.4%), followed by the upper limb
(19.8%), lower back (11.5%), and hip/groin/pelvis (10.7%), 3) the
three most affected specific anatomical sites of GOIs were the knee
(26.3%), shoulder (13%), and the lower back (11.5%), and the most
commonly reported specific GOI was AKP/PFP (14.2%), 4) 55% of
GOIs were soft tissue injuries (muscle, tendon, ligament and nerve),
and 5) almost 50% of cyclists with a GOI reported a symptom
duration of >12 months, 6) almost 60% of hip/groin/pelvis, head,
neck and face, and lower back GOIs were reported as having a
symptom duration of >12months, and 7) >37% of GOIs were severe
enough to reduce or prevent cycling (Grades III and IV).
Although the epidemiology of GOIs has been studied (Barrios
et al., 2015; Clarsen et al., 2010; Dahlquist et al., 2015), there are
substantial methodological differences between studies making
comparisons between studies difficult. Methodological differences
include: differences in terminology and the definition of gradual
onset injuries (Dahlquist et al., 2015; Van der Walt et al., 2014;
Wilber et al., 1995), defining and reporting the exposure (annual
incidence, incidence during single-day or multi-day staged races),
small sample sizes (Dahlquist et al., 2015; Wilber et al., 1995), low-
response rates with possible selection bias (Van der Walt et al.,
2014; Wilber et al., 1995), differences in the populations studied
(ranging from professional cyclists to multistage cycling events)116(Barrios et al., 1997, 2015; Clarsen et al., 2010; De Bernardo et al.,
2012), and use of self-reported data with differences in timing
and content of questionnaire administration (Dahlquist et al., 2015;
Van der Walt et al., 2014; Wilber et al., 1995).
The reported annual incidence of GOIs varies between 17 and
88% (De Bernardo et al., 2012; Van der Walt et al., 2014). However,
in most studies, only elite cyclists were studied where the reported
annual incidence of GOIs is between 17 and 58% (Barrios et al., 1997,
2015; Clarsen et al., 2010; De Bernardo et al., 2012). In two studies
in recreational cyclists, an annual incidence of 85e88%13 11 has been
reported, and we note that this is substantially higher than the
annual incidence we report in our population (2.5%). We attribute
this large variation in annual incidence to the following factors: the
low response rates with potential selection bias in many studies
and variations in the definitions of a GOI used in our study
compared to definitions used in other studies. More specifically, in
our study, we predefined GOI as injuries “severe enough to interfere
with cycling or require treatment e.g. use medication or require you to
seek medical advice from a health professional”. In the other two
studies in recreational cyclists, the definition of GOI included less
“severe” injuries and the response rates were low (Van der Walt
et al., 2014; Wilber et al., 1995) resulting in possible selection bias
and over-reporting of injuries. We are not aware of any studies that
report the lifetime prevalence of GOIs in recreational cyclists, and
therefore we cannot compare our results to other studies. As a
result of these methodological differences, we suggest that a
consensus is developed to standardise definitions and methods of
reporting GOIs in cyclists, based on the IOC consensus guidelines on
methods for recording and reporting of epidemiological data on
injury and illness in sports (Bahr et al., 2020).
In our study, the main anatomical regions of GOIs were reported
in the lower limb (67.9%e82.7%), upper limb (3.8%e10.6%), and
lower back (13.4%e15.1%) (Barrios et al., 1997, 2015; De Bernardo
et al., 2012). We also show that the lower limb is most commonly
affected by GOIs, but we report more GOIs in the upper limb and
fewer GOIs in the lower back compared with other studies. The
precise reasons for these differences are not clear, but could be
related to the level and experience of cyclists in our study (recre-
ational) compared with elite cyclists in other studies (Barrios et al.,
1997, 2015; De Bernardo et al., 2012).
In our study, the three most affected specific anatomical sites for
GOIs were the knee, shoulder, and the lower back and our results are
F. du Toit, M. Schwellnus, P. Wood et al. Physical Therapy in Sport 46 (2020) 113e119very similar to other studies in recreational cyclists: knee (22%e
53.8%), shoulder (17%e30%), and lower back (2.7%e41%) (Dannenberg
et al.,1996; Townes et al., 2005; Van derWalt et al., 2014;Weiss,1985;
Wilber et al., 1995). Other reports also indicate that GOIs affecting the
knee are very common and are the most likely cause of time lost due
to injury in cyclists (Bini et al., 2014; Kotler et al., 2016; Wanich et al.,
2007). In our study, the twomost common specific GOIs affecting the
knee were AKP/PFP and the ITBFS, and this is similar to other studies
(Claes et al., 2015; Deakon, 2012; Farrell et al., 2003). This is a
descriptive study and therefore we did not investigate possible
mechanisms or causes of these knee injuries. We do recognise that
there are multiple possible causal factors for GOIs affecting the knee
in cyclists, including repetitive force application, lower limb biome-
chanical factors such as anatomical malalignment or maltracking,
muscle imbalances, and other factors that could affect the response of
tissue to repetitive mechanical loading and the rate of healing of
microscopic tissue damage. (Lankhorst et al., 2013; Powers et al.,
2017). Causal factors need to be explored in future studies.
The frequency of GOIs by tissue type has only been reported in a
few studies (Barrios et al., 1997, 2015; De Bernardo et al., 2012). We
show that most GOIs were soft tissue injuries and this is consistent
with other studies (ranging from 43.4% to 86% of GOIs) (Barrios
et al., 1997, 2015; De Bernardo et al., 2012). Cycling, by nature, is
not associated with high vertical impact forces and changes in ac-
celeration that characterise other sports e.g. running. Therefore,
gradual onset bony injuries are less common in cycling and most
injuries are in the soft tissues (mostlymuscle, tendon and ligament)
where force generation and force transfer take place. Gradual onset
nerve injuries can be as a result of sustained compression (e.g.
sitting on the saddle) or traction (e.g. in the wrist). A direct com-
parison between frequencies of GOIs and types of GOIs between
these studies is again limited by methodological differences.
The severity of GOIs in recreational cyclists has not been well-
studied and there are substantial differences in the classification
and definitions of measures of severity of GOIs. Measures of
severity grading of GOIs were investigated in six studies (Barrios
et al., 1997, 2015; Clarsen et al., 2010; De Bernardo et al., 2012;
Van der Walt et al., 2014; Wilber et al., 1995), of which only two
were in recreational cyclists (Van derWalt et al., 2014; Wilber et al.,
1995). More severe GOIs ranged from 5.7% to 58.8% in elite cyclists
(Barrios et al., 1997, 2015; Clarsen et al., 2010; De Bernardo et al.,
2012), and 16.5%e25.5% in recreational cyclists (Van der Walt
et al., 2014; Wilber et al., 1995). In our study, the frequency of
more severe GOIs is higher than previous reports in recreational
cyclists, but similar to elite cyclists. We also show that the main
anatomical region where more severe GOIs were reported are the
lower limb, head, neck and face, and the lower back and this is
similar to the findings in some (Weiss, 1985), but not all studies
(Van der Walt et al., 2014; Wilber et al., 1995). Variation in the
definition of “more severe” injuries makes comparison between
study results difficult.
A novel finding in our study is that almost 50% of cyclists with
GOIs reported a symptom duration >12 months. We are aware of
only two studies in recreational cyclists where symptom duration
has been reported. In one study, the duration of neurological
symptoms (symptoms disappearing immediately after cycling to
symptoms for >1 week) in the specific anatomical sites was re-
ported (Van der Walt et al., 2014). In another study, the mean
duration of symptoms in recreational cyclists who sought medical
treatment for GOIs, was 3.7 months (Wilber et al., 1995). We also
show that the main anatomical regions where symptom duration
>12 months is common are hip/groin/pelvis, head, neck and face,
and the lower back. We are not aware of any studies in recreational
cyclists where symptom duration by main anatomical region has
been reported. It is of concern that almost 50% of cyclists with GOIs117report a symptom duration of >12 months. The precise reasons for
the prolonged symptom duration are not clear and was not
explored in this descriptive study. One possible reason is that our
definition of a GOI included more severe injuries (as previously
mentioned). However, it is also likely that there are multiple other
factors at play including that cyclists did not seek attention in cases
of mild symptoms that fluctuate in severity, an incorrect diagnosis
was made or that treatment was not effective resulting in recur-
rence of symptoms. Also, in cases of chronic pain, we recognise that
nociplastic/algopathic/nocipathic (centralisation of pain) pain may
develop after injury and this may also contribute to chronic
symptoms in gradual onset injuries (Hainline et al., 2017). A further
contributing factor may be that >64% of participants were >40
years old. We recommend that further research is needed to
determine the precise reasons for the prolonged duration of
symptoms.
One of the main strengths of this descriptive cross-sectional
study is our large sample size. As far as we are aware, it is the
largest study describing the epidemiology and clinical character-
istics of GOIs in recreational cyclists. Our overall response rate (as a
% of all cycle race entrants) was over 60%, which is high compared
with response rates in other similar studies (Van der Walt et al.,
2014; Wilber et al., 1995). We were also able to show that our
study population was generalizable to all cycle race entrants, but
we note that our study population was significantly older, and that
male cyclists were significantly more represented in this group. Our
results have to be interpreted with this limitation in mind.
One of themost important limitations in our study design is that
our data are self-reported. Therefore, there is not only a potential
for recall bias, but also that the diagnoses of injuries, including the
specific tissue type and the pathology involved could not be veri-
fied by clinical assessment or special investigations. This limits the
value of these results to describe the epidemiology and clinical
characteristics of specific injuries in anatomical areas. However,
self-reported data collection in large descriptive epidemiological
studies on injuries in athletes is an acceptable and commonmethod
(Van der Walt et al., 2014; Weiss, 1985; Wilber et al., 1995), also in
numerous studies on cycling injuries (Clarsen et al., 2010, 2014),
because athletes seek medical attention for injuries and are
generally well-informed about the diagnosis of their injury. Further
limitations of our study are that the definition of injury favoured
reporting of more severe injuries, the maximum reported duration
allowed for injuries was truncated at “>12 months”, which was
reported by almost half of the injured cyclists, severity of injuries
was not reported for 6.8% of the reported injuries, and missing data
for severity was more prevalent among bone injuries compared to
all other tissue type injuries (14% vs 5%, p ¼ 0.0010). We also
acknowledge that data on injury severity are reliant on individual
perceptions of pain to determine the grade of severity. Finally, we
suggest that a prospective design, currently the gold standard for
injury surveillance research, should be used for future studies.
5. Conclusion
GOIs in recreational cyclists have not been well studied. We
report novel data on the epidemiology, clinical characteristics and
severity of GOIs in a large sample of recreational cyclists preparing
for a one-day cycling event. About 1 in 35 recreational cyclists
report ever suffering from a GOI that was severe enough to interfere
with cycling or require treatment or seek medical advice from a
health professional. These GOIs affected mostly the knee, lower
back and shoulder and >37% of injuries were severe enough to
affect training and competition. Of concern is that almost 50% of
cyclists with GOIs report symptom duration >12 months. This is
especially applicable to GOICs of the hip/groin/pelvis, and head/
F. du Toit, M. Schwellnus, P. Wood et al. Physical Therapy in Sport 46 (2020) 113e119neck/face and lower back. We suggest that further research should
focus on determination of the risk factors related with GOIs in
recreational cyclists to design and implement effective injury pre-
vention programs. Education of health professionals on the
appropriate diagnosis and treatment of GOIs is also recommended.
Findings
 About 2.8% (1 in 35) of recreational cyclists report ever suffering
from a GOI that is severe enough to interfere with cycling or
require treatment or seek medical advice from a health
professional.
 GOIs in recreational cyclists affect mostly the knee, lower back
and shoulder.
 >37% of GOIs in recreational cyclists are severe enough to affect
training and competition.
 Almost 50% of cyclists with GOIs report a symptom duration >12
months, perhaps indicating that an appropriate diagnosis was
not made, or treatment was ineffective.Implications
 To our knowledge, the SAFER XIII study is the largest study
documenting the epidemiology and clinical characteristics of
GOIs in recreational cyclists.
 The data on prolonged symptom duration emphasises the need
for cyclists to report injuries timeously, and clinicians to make
an accurate diagnosis and institute appropriate treatment
earlier.
 These data also form the basis for studies to determine risk
factors related to GOIs in recreational cyclists, and this will assist
in planning programs to prevent GOIs.Caution
 The study population was significantly older, and that male
cyclists were significantly more represented in this group. Our
results have to be interpreted with this limitation in mind.
 Specific limitations of our study were that our data are self-
reported, with a potential for recall bias.
 Diagnoses of injuries could not be verified by clinical assessment
or special investigations.
 As this was a cross-sectional study design, we acknowledge that,
from our results, we cannot infer cause-effect.Contributorship
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